[CBAY] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -4,093.32%
YoY- -22.55%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 57 0 31,016 0 0 0 0 -
PBT -41,902 -33,882 -808 -28,778 -26,633 -24,505 -27,094 33.62%
Tax 0 -215 5,900 6,306 9,748 3,142 3,325 -
NP -41,902 -33,882 -808 -35,084 -36,381 -27,647 -30,419 23.72%
Tax Rate - - - - - - - -
Total Cost 41,959 33,882 31,824 35,084 36,381 27,647 30,419 23.84%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -73,512.28 0.00 -2.61 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.37 -0.32 -0.01 -0.36 -0.41 -0.33 -0.36 1.83%
EPS Diluted -0.37 -0.32 -0.01 -0.36 -0.41 -0.31 -0.35 3.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.